IP Library Granted Patent US 12,497,652
Granted Patent B2
US 12,497,652 · App. 17/960,007 · Granted Dec 16, 2025

System and methods for high throughput screening of tissue preparation conditions

Inventors: Kenneth Wang (New York, NY); Rong Fan (Cheshire, CT); Joseph C. Gennaro (New Haven, CT); Colin Ng (New Haven, CT); Matthew Eastman (Woodbridge, CT); Gumaro Rojas (New Haven, CT); Sydney Rossi (Milford, CT); Jose Perez (New Haven, CT); Molly Wetzel (New Haven, CT); Zev Kartiganer (Easton, CT)
Assignee: AtlasXomics Inc.
C12Q1/6841G01N33/6875C12Q2600/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,497,652
App. No.
17/960,007
Granted
Dec 16, 2025
Kind
B2
Abstract

The present disclosure relates generally to systems and methods for screening sample preparation conditions and, more specifically, high throughput screening of tissue sample preparation conditions.

Claims (47)

1 . A method, comprising:

affixing a microfluidic chip having a plurality of channels to a tissue sample such that a first channel of the plurality of channels traverses at least a first region of the tissue sample and a second channel of the plurality of channels traverses at least a second region of the tissue sample;

capturing a first image of the microfluidic chip affixed to the tissue sample that shows a position of at least the first channel and the second channel of the plurality of channels relative to the tissue sample;

flowing a plurality of reagents through the plurality of channels of the microfluidic chip, wherein flowing the plurality of reagents through the plurality of channels comprises:

flowing a first reagent through the first channel, wherein the first reagent interacts with the first region of the tissue sample; and

flowing a second reagent through the second channel, wherein the second reagent interacts with the second region of the tissue sample, wherein the first reagent differs from the second reagent and/or a first characteristic of the interaction between the first reagent and the first region differs from a second characteristic of the interaction between the second reagent and the second region;

removing the microfluidic chip from the tissue sample;

optically marking the tissue sample to identify a quality of the tissue sample and areas in the tissue sample affected by the flow of the plurality of reagents over the tissue sample;

capturing a second image of the tissue sample after removing the microfluidic chip;

co-registering the first and second images resulting in a separation of the second image into a plurality of image regions, wherein a first image region of the plurality of image regions is a first portion of the second image that includes the first region of the tissue sample and a second image region of the plurality of image regions is a second portion of the second image that includes the second region of the tissue sample; and

ranking a performance of the plurality of reagents with the tissue sample based on at least an average brightness of the optical markings captured in one or more image regions of the second image that correspond to a respective reagent of the plurality of reagents.

2 . The method of claim 1 , wherein the first reagent is a first concentration of a permeabilization agent and the second reagent is a second concentration of the permeabilization agent that is different than the first concentration.

3 . The method of claim 1 , wherein the first reagent is a first concentration of an active enzyme and the second reagent is a second concentration of the active enzyme that is different than the first concentration.

4 . The method of claim 1 , wherein the first characteristic differs from the second characteristic on account of the second reagent being flowed through the second channel a predetermined amount of time after the first reagent is flowed through the first channel such that a first incubation time for the first reagent is greater than a second incubation time for the second reagent.

5 . The method of claim 1 , wherein the microfluidic chip is a first microfluidic chip and the method further comprises:

affixing a second microfluidic chip to the tissue sample after removing the first microfluidic chip such that a plurality of channels of the second microfluidic chip are oriented in a different direction than the plurality of channels of the first microfluidic chip; and

flowing a second plurality of reagents through the plurality of channels of the second microfluidic chip.

6 . The method of claim 1 , wherein the ranking of the plurality of reagents is further based on a Pearson correlation between a brightness of a first type of optical marking and a brightness of a second type of optical marking.

7 . The method of claim 6 , wherein the first type of optical marking is generated by a fluorescent DNA stain that marks locations of the tissue sample containing double-stranded DNA.

8 . The method of claim 7 , wherein the second type of optical marking is generated by applying a linker oligo conjugated with a fluorescent molecule to the tissue sample, which marks locations of the tissue sample with transposition sites.

9 . The method of claim 8 , wherein the ranking of the plurality of reagents is further based on a probability transposition sites and double-stranded DNA locations overlap each other.

10 . The method of claim 7 , wherein the second type of optical marking is generated by a fluorescent antibody, which marks locations of the tissue sample that contain a particular type of protein.

11 . The method of claim 10 , wherein the particular type of protein is a glial fibrillary acidic protein.

12 . The method of claim 1 , wherein the first reagent includes a first antibody having a first concentration and the second reagent includes the first antibody having a second concentration different than the first concentration.

13 . The method of claim 12 , wherein optically marking the tissue sample comprises applying a second antibody to the tissue sample, wherein the second antibody is configured to bind with the first antibody and emit a fluorescent light.

14 . The method of claim 1 , wherein co-registering the first and second images further comprises grouping the plurality of image regions into groups corresponding to each of the plurality of reagents.

15 . A non-transitory computer-readable storage medium storing one or more programs, the one or more programs comprising instructions, which when executed by one or more processors of an electronic system, cause the electronic system to:

affix a microfluidic chip having a plurality of channels to a tissue sample such that a first channel of the plurality of channels traverses at least a first region of the tissue sample and a second channel of the plurality of channels traverses at least a second region of the tissue sample;

capture a first image of the microfluidic chip affixed to the tissue sample that shows a position of at least the first channel and the second channel of the plurality of channels relative to the tissue sample;

flow a plurality of reagents through the plurality of channels of the microfluidic chip, wherein flowing the plurality of reagents through the plurality of channels comprises:

flowing a first reagent through the first channel, wherein the first reagent interacts with the first region of the tissue sample; and

flowing a second reagent through the second channel, wherein the second reagent interacts with the second region of the tissue sample, wherein the first reagent differs from the second reagent and/or a first characteristic of the interaction between the first reagent and the first region differs from a second characteristic of the interaction between the second reagent and the second region;

removing the microfluidic chip from the tissue sample;

optically mark the tissue sample to identify a quality of the tissue sample and areas in the tissue sample affected by the flow of the plurality of reagents over the tissue sample;

capture a second image of the tissue sample after removing the microfluidic chip;

co-register the first and second images resulting in a separation of the second image into a plurality of image regions, wherein a first image region of the plurality of image regions is a first portion of the second image that includes the first region of the tissue sample and a second image region of the plurality of image regions is a second portion of the second image that includes the second region of the tissue sample; and

rank a performance of the plurality of reagents with the tissue sample based on at least an average brightness of the optical markings captured in one or more image regions of the second image that correspond to a respective reagent of the plurality of reagents.

16 . A non-transitory computer-readable storage medium storing one or more programs, the one or more programs comprising instructions, which when executed by one or more processors of an electronic system, cause the electronic system to:

receive a first image of a microfluidic chip having a plurality of channels that was affixed to a tissue sample such that a first channel of the plurality of channels traverses at least a first region of the tissue sample and a second channel of the plurality of channels traverses at least a second region of the tissue sample;

receive a second image of the tissue sample after:

a plurality of reagents were flowed through the plurality of channels of the microfluidic chip, wherein flowing the plurality of reagents through the plurality of channels comprised:

flowing a first reagent through the first channel, wherein the first reagent interacts with the first region of the tissue sample; and

flowing a second reagent through the second channel, wherein the second reagent interacts with the second region of the tissue sample, wherein the first reagent differs from the second reagent and/or a first characteristic of the interaction between the first reagent and the first region differs from a second characteristic of the interaction between the second reagent and the second region;

removing the microfluidic chip from the tissue sample; and

optically marking the tissue sample to identify a quality of the tissue sample and areas in the tissue sample affected by the flow of the plurality of reagents over the tissue sample;

co-register the first and second images resulting in a separation of the second image into a plurality of image regions, wherein a first image region of the plurality of image regions is a first portion of the second image that includes the first region of the tissue sample and a second image region of the plurality of image regions is a second portion of the second image that includes the second region of the tissue sample; and

rank a performance of the plurality of reagents with the tissue sample based on at least an average brightness of the optical markings captured in one or more image regions of the second image that correspond to a respective reagent of the plurality of reagents.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 20, 2025
From: WANG, KENNETH; FAN, RONG; GENNARO, JOSEPH C.; NG, COLIN; EASTMAN, MATTHEW; ROJAS, GUMARO; ROSSI, SYDNEY; PEREZ, JOSE; WETZEL, MOLLY; KARTIGANER, ZEV
To: ATLASXOMICS INC.
Reel/Frame 072985/0657 →
CONFIRMATORY LICENSE Recorded Jan 25, 2024
From: YALE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 066370/0181 →
Continuity (2)
Provisional Application 63252091 · Oct 4, 2021
Related Publication 20230139059A1 · May 4, 2023
References Cited (24)
US 10071377B2 · Bharadwaj · 2018 [cited by examiner]
US 20200152289A1 · Cleary et al. · 2020 [cited by applicant]
US 20210095331A1 · Fan et al. · 2021 [cited by applicant]
US 20220073974A1 · Gennaro · 2022 [cited by applicant]
WO 2017172762A1 · 2017 [cited by applicant]
WO 2019113506A1 · 2019 [cited by applicant]
WO 2019178164A1 · 2019 [cited by applicant]
WO 2020047004A2 · 2020 [cited by applicant]
WO 2020123309A1 · 2020 [cited by applicant]
WO 2021091611A1 · 2021 [cited by applicant]
WO 2022051669A1 · 2022 [cited by applicant]
WO 2023059658A1 · 2023 [cited by applicant]
Liu et al., “High-Spatial-Resolution Multi-Omics Sequencing via Deterministic Barcoding in Tissue”, Cell, vol. 183, No. 6, Dec. 10, 2020, pp. 1665-1681. [cited by applicant]
International Preliminary Report on Patentability received for PCT Patent Application No. PCT/US2021/049148, mailed on Mar. 7, 2023, 7 pages. [cited by applicant]
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2021/049148, mailed on Nov. 24, 2021, 10 pages. [cited by applicant]
International Search Report and Written Opinion received for PCT Patent Application No. PCT/US2022/045698, mailed on Jan. 27, 2023, 15 pages. [cited by applicant]
Non-Final Office Action received for U.S. Appl. No. 17/466,911, mailed on Apr. 11, 2023, 23 pages. [cited by applicant]
Office Action received for European Patent Application No. 21790312.9, mailed on Apr. 13, 2023, 3 pages. [cited by applicant]
Cao et al., “Comprehensive single-cell transcriptional profiling of a multicellular organism”, Science 357, Aug. 18, 2017, 661-667. [cited by applicant]
Crosetto et al., “Spatially resolved transcriptomics and beyond”, Nature Review Genetics, vol. 16, Jan. 2015, pp. 57-66. [cited by applicant]
Liu et al., “High-Spatial-Resolution Multi-Omics Atlas Sequencing of Mouse Embryos via Deterministic Barcoding in Tissue”, Oct. 1, 2019, 55 pages. [cited by applicant]
Rory et al., “RNA sequencing: the teenage years”, Nature Review Genetics, vol. 20, Nov. 2019, pp. 631-656. [cited by applicant]
Rosenberg et al., “Single-cell profiling of the developing mouse brain and spinal cord with split-pool barcoding”, Science 360, Apr. 13, 2018, 176-182. [cited by applicant]
Shah et al., “Dynamics and Spatial Genomics of the Nascent Transcriptome by Intron seqFISH”, vol. 174, No. 2, Retrieved from the Internet:—https://www.sciencedirect.com/science/article/pii/S0092867418306470, Jul. 2018, … [cited by applicant]